Ottobock stands for innovative products, developed with the knowledge of a successful hundred-year company history. A global medical technology company with holistic care has emerged from the specialist in prosthetics. Since 2018 we have been using our know-how, under the name Ottobock SE & Co. KGaA, for permanently healthy workplaces.
In 2019, we invested 9 percent of our sales in research and development. In order to improve the lives of our users, we are constantly developing the company and the technology.
More freedom of movement and the prevention of bad posture have been made possible by products and technologies from Ottobock since 1919. While the market and the supply of mass-produced prosthesis components were revolutionized when Ottobock was founded, the focus today is on high-tech products. The Paexo exoskeleton family for ergonomic workplaces. Microprocessor-controlled knee joints such as the C‑Leg — with control via app — or the C‑Brace leg orthosis. Juvo power wheelchairs or the multi-articulating hand bebionic.
As a global technology leader in “Wearable Human Bionics” — wearable human bionics, we strive to create a better quality of life and replace or expand parts of the human body.
Ottobock products & services
Ottobock has been providing people with disabilities with new, better prostheses time and again since it was founded. That is why we are the technology and world market leader in exoprosthetics.
We support the treatment of people all over the world with orthotic aids. These relieve, stabilize or immobilize, like splints or bandages, or guide the limbs or the trunk. Our paralysis orthoses, for example, mobilize people with partial paralysis in their legs.
Mobility and participation
In this sub-area, our offer ranges from electric and manual wheelchairs to rehabilitation products such as seat cushions or standing aids. Starting from our wheelchair production center in Königsee, Thuringia, we are opening new production locations around the world.
Ottobock operates more than 240 supply centers worldwide. Thanks to our service-oriented patient care and ongoing production improvements in our orthopedic production centers, we are always close to people.
Ottobock exoskeletons have been supporting working people with heavy physical activities since 2018. In this new market segment we help people to work symptom-free, from vehicle manufacture to high-tech manufacture.
Ottobock SE & Co. KGaA
- 2019 over € 1 billion in sales
- globally more than 8,000 employees in over 50 countries
- over 240 in-house patient care centers
- No. 1 in the global prosthetic market
Well-positioned family company
We draw the strength from our values to passionately drive innovation. Our more than 8,000 employees created a turnover of more than 1,000 million euros in 2019 for Ottobock SE & Co. KGaA.
The direct descendants of the founding father Otto Bock own 100% of the Näder Holding GmbH & Co. KG. This in turn holds 80% of Ottobock SE & Co. KGaA.
With the right investor for lasting success
EQT, Sweden’s private equity company, has owned 1/5 of Ottobock SE & Co. KGaA since 2017. Since then, we have played a leading role in the digitization of orthopedic medical technology worldwide. With EOT we design our well-founded, lucrative growth potential in a targeted and effective manner.